Home › Funds › AQR Capital Management › REGN
AQR Capital Management position in REGN
REGENERON PHARMACEUTICALS INC. · Health Care
Latest position (Q2 2026)1.13M sh
Reported value held$702.16M
Portfolio Weight0.25%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 276.03K | $167.05M | New |
| Q4 2021 | 449.62K | $283.94M | Add |
| Q1 2022 | 508.78K | $355.34M | Add |
| Q2 2022 | 550.42K | $323.17M | Add |
| Q3 2022 | 430.30K | $296.42M | Reduce |
| Q4 2022 | 309.15K | $221.22M | Reduce |
| Q1 2023 | 240.77K | $197.73M | Reduce |
| Q2 2023 | 219.65K | $155.06M | Reduce |
| Q3 2023 | 190.17K | $156.50M | Reduce |
| Q4 2023 | 195.88K | $171.85M | Add |
| Q1 2024 | 182.45K | $175.23M | Reduce |
| Q2 2024 | 189.29K | $198.57M | Add |
| Q3 2024 | 225.53K | $235.23M | Add |
| Q4 2024 | 207.09K | $147.10M | Reduce |
| Q1 2025 | 235.95K | $148.66M | Add |
| Q2 2025 | 114.74K | $59.68M | Reduce |
| Q3 2025 | 721.35K | $405.60M | Add |
| Q4 2025 | 995.71K | $768.52M | Add |
| Q1 2026 | 1.23M | $946.01M | Add |
| Q2 2026 | 1.13M | $702.16M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding REGN
- Vanguard Group 9.08M sh · $7.00B · Q4 2025
- BlackRock Inc 9.11M sh · $5.68B · Q2 2026
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- Invesco Ltd 3.94M sh · $2.46B · Q2 2026
- JPMorgan Chase & Co 3.77M sh · $2.38B · Q2 2026
- Franklin Resources 2.77M sh · $1.73B · Q2 2026
- Geode Capital Management 2.63M sh · $1.63B · Q2 2026
- Morgan Stanley 1.40M sh · $871.53M · Q2 2026
- Goldman Sachs Group 1.33M sh · $831.98M · Q2 2026
- Bank of America Corp 1.29M sh · $805.02M · Q2 2026
- Wellington Management Group 1.27M sh · $791.95M · Q2 2026
- Norges Bank Investment Management 1.17M sh · $731.29M · Q2 2026